Research articleperformance liquid chromatography with fluorescence [29,30] or UV detection [31][32][33][34][35], liquid chromatography tandem mass spectrometry (LC/MS/MS) [36,37] and capillary electrophoresis [38,39] are also reported for determination of moxifloxacin hydrochloride from human body fluids. British Pharmacopoeia (BP) [40] employs HPLC method for the assay of moxifloxacin hydrochloride in pharmaceutical preparations. Further, the BP describes no environmentally friendly chromatographic procedure since acetonitrile is one of the components of mobile phase.This work describes a rapid and sensitive RP-HPLC method with UV detection for determination of moxifloxacin hydrochloride in bulk drug and tablet formulation with low cost of mobile phase, which was used for the first time in this work. This method serves as an alternative to the methods described in pharmacopoeias and can be conveniently used for routine quality control analysis of moxifloxacin.
Experimental MaterialsHPLC grade methanol (Merck, Germany), formic acid (AR grade, Surechem Products LTD, England) and water (HPLC grade, Merck). Moxifloxacin hydrochloride (MOXF) pure drug substance, its purity was found to be 99.7%, and rosuvastatin calcium (ROSV) was obtained from Matrix Laboratories Limited and MSN Laboratories Limited (India), respectively. Tablets were purchased from Syrian market, containing moxifloxacin hydrochloride 400 mg per tablet.
AbstractSimple, rapid, sensitive and accurate method for determination of moxifloxacin HCl (MOXF) in bulk drug and tablet formulation was developed and validated by using HPLC. Rosuvastatin calcium (ROSV) was used as internal standard. Chromatography was performed with mobile phase consisted of 0.1 M formic acid (pH 2.80) and methanol (30:70, v/v), with a flow rate of 1.0 mL/min, Nucleodur C18 column (250 mm×4.6 mm i.d., 5 m particle size) and photodiode array (PDA) detection at 280 nm. The method was validated for linearity, specificity, accuracy, precision, stability and robustness. Linearity range was 1.12-590.0 µg/mL with limit of detection value of 0.23 µg/mL. The precision of the method was demonstrated using intraand inter-day assay RSD% values which were less than 2%, while the recovery was 99.11-103.85%. The developed method was very rapid with a run time of 3 min and found to be successively applied for the quality control of MOXF in bulk drug and tablets.